SCHEMBL30208541

SCHEMBL30208541

NC(=O)CC[C@H](N)C(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.63

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.58
ADORA2B P29275 1/20 0.58
ADORA1 P30542 2/20 0.57
QARS1 P47897 1/20 0.57
ALDH1A1 P00352 1/20 0.56
LMNA P02545 1/20 0.56
GLA P06280 1/20 0.56
PMP22 Q01453 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
ADORA3 P0DMS8 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30208537 0.93 LMNA (0.58) ADORA2AADORA2BADORA1ALDH1A1LMNA
SCHEMBL30208584 0.91 ADORA2A (0.59) ADORA2AADORA2BADORA1ALDH1A1LMNA
SCHEMBL3898255 0.88 P2RY12 (0.65) ADORA1QARS1SMN1; SMN2
SCHEMBL30208574 0.87 LMNA (0.60) ADORA2AADORA2BADORA1ALDH1A1LMNA
SCHEMBL2480941 0.86 ADORA2A (0.62) ADORA2AADORA2BALDH1A1PMP22
SCHEMBL28477260 0.85 ADORA2A (0.67) ADORA2AADORA2BADORA1ALDH1A1LMNA
SCHEMBL29047905 0.84 ADORA2A (0.60) ADORA2AADORA2BALDH1A1PMP22
SCHEMBL29047902 0.84 ADORA2A (0.60) ADORA2AADORA2BALDH1A1PMP22
SCHEMBL30208581 0.84 HIF1A (0.53) QARS1ADORA3
SCHEMBL854222 0.84 ADORA3 (0.70) ADORA2AADORA2BADORA1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023001982-A1 MR1 LIGANDS AND PHARMACEUTICAL COMPOSITIONS FOR IMMUNOMODULATION UNIVERSITÄT BASEL (CH) 2023-01-26 WO claimed
WO-2023001982-A1 MR1 LIGANDS AND PHARMACEUTICAL COMPOSITIONS FOR IMMUNOMODULATION UNIVERSITÄT BASEL (CH) 2023-01-26 WO disclosed